Navigation Links
Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
Date:2/22/2010

ost of revenues 99,673 (19,339) (1) 80,334 Selling, general and administrative 145,003 - 145,003 Research and development 48,705 (15,979) (2) 32,726 Impairment of intangibles 69,000 (69,000) (3) - Acquisition-related items (134,303) 134,303 (4) - Operating income 163,328 (29,985) 133,343 Interest (income) expense, net 9,505 (4,020) (5) 5,485 Other (income) expense, net (1,725) 1,555 (6) (170) Income before income taxes 155,548 (27,520) 128,028 Income taxes 7,700 25,181 (7) 32,881 Net income $147,848 $(52,701) $95,147 Diluted earnings per share $1.25 $0.81 Diluted weighted average shares 117,859 117,859 Notes to reconciliation of our GAAP statements of operations to our adjusted statements of operations: (1) To exclude amortization of commercial intangible assets related to marketed products of $19,217 and the impact of an Indevus inventory step-up recorded as part of acquisition accounting of $122. (2) To exclude upfront and milestone payments to partners. (3) To exclude the impairment of AVEED and PRO2000 for $65,000 and $4,000, respectively. (4) To exclude Indevus transaction and separation cost reversals of ($2,973) as well as the impact, under purchase accounting, of a gain recorded to reflect the change in the company's current estimate of fair value, in accordance with GAAP, of the contingent consideration associated with the Indevus acquisitio
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... , Sept. 1, 2014 Reportbuyer.com has ... Brazil Aesthetic Lasers and Energy Devices Market ... https://www.reportbuyer.com/product/2343455/Brazil-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html Brazil Aesthetic Lasers and ... Summary GlobalData,s new report, "Brazil ... 2020", provides key market data on the Brazil ...
(Date:9/1/2014)... NEW YORK , Sept. 1, 2014 /PRNewswire/ ... new market research report is available in its ... Edition), 2014 - 2024 ... conjugates (ADCs) are a new class of therapeutic ... small pharmaceutical companies. Generally addressed as the marriage ...
(Date:9/1/2014)... Sept. 1, 2014 Reportlinker.com announces that ... its catalogue:  Drug Discovery Technologies - A ... http://www.reportlinker.com/p02349116/Drug-Discovery-Technologies---A-Global-Market-Overview.html The development of new ... requires extensive expenditure, in addition to consuming a ... a new drug involves the utilizing high-throughput screening ...
Breaking Medicine Technology:Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 2Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 3Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 4Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 5Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 6Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 7Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 8Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 9Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 10Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 11Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 12Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 13Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 14Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 15Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 16Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 17Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 18Drug Discovery Technologies - A Global Market Overview 2Drug Discovery Technologies - A Global Market Overview 3Drug Discovery Technologies - A Global Market Overview 4Drug Discovery Technologies - A Global Market Overview 5Drug Discovery Technologies - A Global Market Overview 6Drug Discovery Technologies - A Global Market Overview 7Drug Discovery Technologies - A Global Market Overview 8Drug Discovery Technologies - A Global Market Overview 9Drug Discovery Technologies - A Global Market Overview 10Drug Discovery Technologies - A Global Market Overview 11
... ... Dysmenorrhea Pain Medication, HOBOKEN, N.J., June 18 A ... periods,affecting millions of women each year, can be reduced naturally ... maritime,pine tree. The multi- center field study, published in the ...
... the Need for Testosterone Screening in At-Risk ... ... from a 12-month,international, multi-center study showed that treatment for low,testosterone with ... and sexual function among,hypogonadal men with Type 2 diabetes and/or Metabolic ...
Cached Medicine Technology:New Study: Pine Bark Significantly Reduces Menstrual Pain 2New Study: Pine Bark Significantly Reduces Menstrual Pain 3Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome 2Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome 3
(Date:9/1/2014)... 2014 iFitDress.com, a professional company of ... new selection of modest evening dresses . In ... on these great evening gowns. All customers can enjoy ... 16, 2014. , iFitDress.com is one of the ... and production workers are striving to create more trendy ...
(Date:9/1/2014)... September 02, 2014 Top10BestSEOHosting.com is a ... compared many top web hosting companies and announced that ... suppliers in August. , GreenGeeks ( http://www.greengeeks.com/cgi-bin/affiliates/clickthru.cgi?id=seohosts ) ... the USA. The company has a lot of useful ... get great products at low rates. , As ...
(Date:9/1/2014)... “Australia Hernia Repair Market Outlook to ... Repair market. The report provides value, in millions of ... US dollars) within market segments –, ... ,     Composite Meshes and Biological Meshes. ... the correction of a hernia (a bulging of internal ...
(Date:9/1/2014)... Building on the success of the ... and Breathing Academy (ASBA) has officially announced its ... Professionals. The event will be taking place at the ... 11th. This years’ event promises to be yet another ... , In recent years, Pro Player Health Alliance ...
(Date:9/1/2014)... (HealthDay News) -- Having regular family meals may help ... "cyberbullying," a new study suggests. Online abuse can ... experts. "One in five adolescents experience cyberbullying," Frank ... Social Policy at McGill University in Montreal, said in ... media, and online harassment and abuse are difficult for ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: New Modest Evening Wear Selection Now Unveiled Online 2Health News:The Best Reseller Hosting Suppliers in August Released by Leading Review SiteTop10BestSEOHosting.com 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 3Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 4Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 2Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 3Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 4Health News:Family Meals May Defuse Cyberbullying's Impact, Study Says 2
... Up 23% - Gross Profit Decreases ... - Pre-Tax Income ... - Net income $888,000; EPS $.05, MORTON GROVE, Ill., ... beverage,called kefir, announced today for the first quarter ended March 31, 2008,total sales increased 23% ...
... to Pain and Injury Risk, ALEXANDRIA, Va., May ... that biking to work not only provides,excellent health benefits ... Bike to Work Day on Friday, May 16, the ... lower their,risk of injury by ensuring that their bicycles ...
... /PRNewswire-FirstCall/ - LMS Medical Systems,(TSX:LMZ), a healthcare technology ... systems for obstetrics, today announced that it has,entered ... LLC,(Regional) of New Jersey to license CALM Shoulder ... Obstetricians and Gynecologists in New Jersey,serving over 200,000 ...
... are more likely to suffer from a larger number ... more than 5,000 men and women published in the ... Researchers hope the results will help clinicians to understand ... more effectively. , According to the Boston Area ...
... OmniGuide, Inc., the developer,of the first and ... in,minimally invasive surgery, today announced the closing of ... Group, a healthcare venture capital,and private equity firm, ... Ray Stata, Stata Venture Partners, 3i, Argonaut,Ventures, ESI, ...
... N.J., May 15 Chemical sourcing executives,from the ... issues during the Pharma ChemOutsourcing Conference on September ... that such an impressive gathering of,industry management has ... of materials and services to support R & ...
Cached Medicine News:Health News:Lifeway Foods Reports Record 1st Quarter 2008 Results 2Health News:Lifeway Foods Reports Record 1st Quarter 2008 Results 3Health News:Lifeway Foods Reports Record 1st Quarter 2008 Results 4Health News:Physical Therapists Offer Tips for Proper Bike Fit in Support of National Bike to Work Day 2Health News:Physical Therapists Offer Tips for Proper Bike Fit in Support of National Bike to Work Day 3Health News:Physical Therapists Offer Tips for Proper Bike Fit in Support of National Bike to Work Day 4Health News:LMS CALM Shoulder Screen(TM) selected by New Jersey physician group to minimize obstetrical risks 2Health News:LMS CALM Shoulder Screen(TM) selected by New Jersey physician group to minimize obstetrical risks 3Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 2Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 3Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 4Health News:OmniGuide(R) Secures $25 Million in Funding to Support Continued Growth and New Market Penetration 2Health News:OmniGuide(R) Secures $25 Million in Funding to Support Continued Growth and New Market Penetration 3Health News:11 Pharmaceutical Titans Headline Chemistry Outsourcing Conference Program in September in New Jersey 2
Toxoplasma IgG II ELISA...
ELISA kit for CMV CAP M....
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of small sized foreign bodies....
Blunt tipped forceps with a thin tip angled at approximately 135 and hollowed out "notch" on the interior of the distal end. Tip is shaped like a pic when in the closed position. For membrane peeling...
Medicine Products: